Ceruloplasmin Protein <div class="infobox infobox-protein">
Overview Ceruloplasmin (CP) is a blue-green, multifunctional glycoprotein that serves as the major copper carrier in plasma and a critical ferroxidase in iron metabolism. It converts toxic Fe²⁺ to Fe³⁺ for iron storage and transport. In the brain, ceruloplasmin is produced by [astrocytes](/entities/astrocytes) and plays essential roles in iron homeostasis, oxidative stress protection, and dopamine metabolism. Ceruloplasmin deficiency causes aceruloplasminemia, a devastating neurodegenerative disorder[@linder1996].
Structure ...
Ceruloplasmin Protein <div class="infobox infobox-protein">
Overview Ceruloplasmin (CP) is a blue-green, multifunctional glycoprotein that serves as the major copper carrier in plasma and a critical ferroxidase in iron metabolism. It converts toxic Fe²⁺ to Fe³⁺ for iron storage and transport. In the brain, ceruloplasmin is produced by [astrocytes](/entities/astrocytes) and plays essential roles in iron homeostasis, oxidative stress protection, and dopamine metabolism. Ceruloplasmin deficiency causes aceruloplasminemia, a devastating neurodegenerative disorder[@linder1996].
Structure Ceruloplasmin is a single-chain, 1046-amino acid glycoprotein:
Multicopper oxidase domain : Contains 6 tightly bound copper atoms essential for ferroxidase activityThree major domains : Each with distinct structural rolesGlycosylation : Extensive N-linked glycosylation (25% carbohydrate by weight)Active sites : Separate copper-binding sites for electron transfer and substrate oxidationThe protein requires copper for proper folding and enzymatic function[@bento2007].
Normal Function In the nervous system, ceruloplasmin is critical for:
Iron metabolism : Ferroxidase activity converts Fe²⁺ to Fe³⁺ for transferrin bindingCopper transport : Carries >95% of circulating copperAntioxidant defense : Scavenges free radicals, inhibits iron-induced oxidationDopamine synthesis : Required for dopamine β-hydroxylase (dopamine to norepinephrine)Angiogenesis : Promotes blood vessel formation in the CNSAstrocyte function : Secreted by astrocytes, supports neuronal iron handlingRole in Neurodegeneration
Aceruloplasminemia This autosomal recessive disorder (CP gene mutations) causes:
Progressive retinal degeneration
Diabetes mellitus
Neurological deterioration (ataxia, dementia, parkinsonism)
Brain iron accumulation in basal ganglia and cerebellum
Average onset in 4th decade, leading to premature death[@kono2014]
Parkinson's Disease
Reduced ceruloplasmin levels in PD patients
CP mutations/single nucleotide polymorphisms associated with PD risk
Impaired iron metabolism contributes to substantia nigra iron accumulation
Decreased ferroxidase activity may accelerate dopaminergic neuron loss
Ceruloplasmin as potential PD biomarker[@trsdttir]
Alzheimer's Disease
Altered ceruloplasmin levels in AD brain and CSF
Copper dysregulation in AD brain
May contribute to amyloid-β copper redox cycling and oxidative stress
Genetic variants in CP associated with AD risk
Amyotrophic Lateral Sclerosis (ALS)
Elevated ceruloplasmin in ALS patients
May reflect compensatory response to oxidative stress
Altered copper metabolism in motor neuron disease
Wilson's Disease
Though primarily a copper toxicosis disorder, ceruloplasmin is affected
Low ceruloplasmin is a diagnostic marker (though not specific)
Neurological manifestations include tremor, dysarthria, dystonia
Therapeutic Targeting Current therapeutic approaches include:
Enzyme replacement : Not available (protein is too large for CNS delivery)Copper supplementation : May help some CP mutants retain functionIron chelation : For aceruloplasminemia (Deferoxamine, Deferasirox)Gene therapy : AAV-CP delivery in preclinical modelsSmall molecule ferroxidases : As potential CP mimeticsNo ceruloplasmin-targeted drugs are in clinical trials for neurodegeneration[^5].
Key Publications
[Harris et al., Ceruloplasmin in brain iron metabolism (1999)](https://pubmed.ncbi.nlm.nih.gov/10439956/). Journal of Neural Transmission .
[Vassiliev et al., Structure of ceruloplasmin (2005)](https://doi.org/10.1016/j.jmb.2005.07.032). Journal of Molecular Biology .
[Miyajima et al., Aceruloplasminemia (2015)](https://pubmed.ncbi.nlm.nih.gov/25636921/). Brain & Development . 4延. [Boll et al., Ceruloplasmin and Parkinson's disease (2008)](https://pubmed.ncbi.nlm.nih.gov/18797168.). Journal of Neural Transmission .
[Ayton et al., Ceruloplasmin and neurodegeneration (2013)](https://doi.org/10.1016/j.neurobiolaging.2012.08.018). Neurobiology of Aging .
See Also
[CP Gene](/entities/cp)
[Iron Metabolism in Neurodegeneration](/mechanisms/iron-metabolism-neurodegeneration)
[Aceruloplasminemia](/diseases/aceruloplasminemia)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Alzheimer's Disease](/diseases/alzheimers-disease)
External Links
[UniProt P00450](https://www.uniprot.org/uniprot/P00450)
[NCBI Gene: 1356](https://www.ncbi.nlm.nih.gov/gene/1356)
[OMIM: 117700](https://www.omim.org/entry/117700)
References
[Linder & Hazegh-Azam, Ceruloplasmin and copper in biology (1996)](https://pubmed.ncbi.nlm.nih.gov/8755472/)
[Bento et al, Copper and ceruloplasmin in neurodegeneration (2007)](https://doi.org/10.1016/j.bbadis.2007.01.004)
[Kono et al, Aceruloplasminemia: molecular characterization (2014)](https://pubmed.ncbi.nlm.nih.gov/23845631/)
[Tórsdóttir et al, Ceruloplasmin, iron and copper in Parkinson's disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/16247079/) Show full description